---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-172585"
form_type: "8-K"
ticker: "MNOV"
cik: "0001226616"
company_name: "MEDICINOVA INC"
filed_at: "2023-06-22T23:59:59+00:00"
generated_at: "2026-06-13T18:48:15.451959+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# MediciNova receives two Nasdaq deficiency notices for board and audit committee independence

## Summary
- Received Audit Committee Notice on June 15, 2023 due to committee having two independent members instead of three.
- Received Independent Board Notice on June 22, 2023 for having only two independent directors out of five board seats.
- Cure period: until the earlier of next annual meeting or June 13, 2024 (or Dec 11, 2023 if meeting before then).
- Company plans to appoint an additional independent director; no immediate impact on stock listing or trading.

## SEC filing metadata
- accession: 0001193125-23-172585
- form_type: 8-K
- ticker: MNOV
- cik: 0001226616
- company_name: MEDICINOVA INC
- filed_at: 2023-06-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1226616/000119312523172585/0001193125-23-172585-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1226616/000119312523172585/d512906d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-172585
- JSON: https://secwatch.observer/filing/0001193125-23-172585.json
- Plain text: https://secwatch.observer/filing/0001193125-23-172585.txt

## Key facts
- Listing & Compliance Notices
  MEDICINOVA INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: audit committee
  - Rules: 5605(c)(2)(A), 5605(b)(1)
  source text: June 15, 2023, MediciNova, Inc. (the “Company”) received a letter (the “Audit Committee Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, due to Jeff Himawan, Ph.D. not standing for re-election as a Class I director of the Company at the Company’s 2023 annual meeting of stockholders held on June 13, 2023 (the “Annual Meeting”), the Company was no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A) (the “Audit Committee Listing Rule”), which requires the Audit Committee (the “Audit Committee”) of the Board of Directors (the “Board”) of the Company to be co
  evidence_url: https://www.sec.gov/Archives/edgar/data/1226616/000119312523172585/0001193125-23-172585-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.